Thus, decreased HSP90AB1 expression in CRC with a poorer prognosis may represent an inadvertent bystander effect resulting from a CRC-specific selective pressure toward mTOR pathway activation as a consequence of USP22 downregulation6. The gene discussed is USP22; the disease is colorectal carcinoma.